| | | |
Cause-specific death
|
Death from other causes
|
|---|
|
Characteristics
|
N (%)
|
Event
|
5-year (%)
|
P
|
5-year (%)
|
P
|
|---|
|
Total
|
40043
|
7216
|
7.1 (6.8 to 7.3)
| |
7.4 (7.1 to 7.6)
| |
|
Age (years)
| | | |
< 0.001
| |
< 0.001
|
|
20–39 years
|
5940 (14.8)
|
262
|
3.3 (2.8 to 3.7)
| |
0.4 (0.3 to 0.6)
| |
|
40–64 years
|
20766 (51.9)
|
2069
|
5.7 (5.4 to 6.0)
| |
2.3 (2.1 to 2.5)
| |
|
65+ years
|
13337 (33.3)
|
4885
|
10.8 (10.3 to 11.3)
| |
18.2 (17.5 to 18.9)
| |
|
Sex
| | | |
< 0.001
| |
< 0.001
|
|
Male
|
22295 (55.7)
|
4901
|
8.7 (8.3 to 9.1)
| |
8.9 (8.5 to 9.3)
| |
|
Female
|
17748 (44.3)
|
2315
|
5.0 (4.7 to 5.3)
| |
5.4 (5.1 to 5.8)
| |
|
Race
| | | |
< 0.001
| |
0.006
|
|
White
|
39559 (98.8)
|
7075
|
6.9 (6.6 to 7.1)
| |
7.4 (7.1 to 7.7)
| |
|
Non-white
|
484 (1.2)
|
141
|
20.7 (17.2 to 24.4)
| |
4.2 (2.7 to 6.3)
| |
|
Melanoma subtype
| | | |
< 0.001
| |
< 0.001
|
|
Superficial spreading melanoma
|
13444 (33.6)
|
1645
|
3.9 (3.6 to 4.2)
| |
5.4 (5.0 to 5.8)
| |
|
Nodular melanoma
|
2875 (7.2)
|
1233
|
25.6 (24.0 to 27.2)
| |
12.1 (10.9 to 13.3)
| |
|
Lentigo maligna melanoma
|
2383 (6.0)
|
547
|
3.4 (2.7 to 4.2)
| |
14.5 (13.1 to 16.0)
| |
|
Melanoma, NOS
|
18926 (47.3)
|
3131
|
6.2 (5.9 to 6.5)
| |
6.9 (6.5 to 7.3)
| |
|
Others
|
2415 (6.0)
|
660
|
12.8 (11.5 to 14.2)
| |
9.2 (8.1 to 10.4)
| |
|
Anatomic sites
| | | |
< 0.001
| |
<0.001
|
|
Extremities
|
18427 (46.0)
|
2811
|
5.9 (5.6 to 6.3)
| |
6.2 (5.9 to 6.6)
| |
|
Trunk
|
13987 (34.9)
|
2250
|
6.9 (6.5 to 7.3)
| |
5.9 (5.5 to 6.3)
| |
|
Face and ears
|
4819 (12.0)
|
1331
|
8.0 (7.2 to 8.8)
| |
13.8 (12.8 to 14.8)
| |
|
Scalp and neck
|
2810 (7.0)
|
824
|
13.9 (12.6 to 15.2)
| |
10.8 (9.6 to 11.9)
| |
|
Thickness (mm)
| | | |
< 0.001
| |
< 0.001
|
|
≤ 1.00
|
28017 (70.0)
|
3086
|
2.2 (2.0 to 2.4)
| |
5.9 (5.7 to 6.3)
| |
|
1.01–2.00
|
6279 (15.7)
|
1415
|
9.4 (8.7 to 10.2)
| |
8.1 (7.5 to 8.8)
| |
|
2.01–4.00
|
3464 (8.9)
|
1391
|
21.2 (19.9 to 22.6)
| |
11.8 (10.8 to 12.9)
| |
|
> 4.00
|
2283 (5.7)
|
1324
|
38.1 (36.1 to 40.1)
| |
15.2 (13.7 to 16.7)
| |
|
Ulceration
| | | |
< 0.001
| |
< 0.001
|
|
Absent
|
35065 (87.6)
|
4916
|
4.1 (3.9 to 4.3)
| |
6.6 (6.3 to 6.8)
| |
|
Present
|
4978 (12.4)
|
2300
|
27.6 (26.4 to 28.9)
| |
12.8 (11.9 to 13.8)
| |
|
Lymph node status
| | | |
< 0.001
| |
< 0.001
|
|
N0
|
37363 (93.3)
|
5889
|
4.8 (4.6 to 5.0)
| |
7.4 (7.1 to 7.7)
| |
|
N1
|
1543 (3.9)
|
650
|
31.0 (28.7 to 33.4)
| |
6.0 (4.9 to 7.3)
| |
|
N2
|
762 (1.9)
|
401
|
38.8 (35.5 to 42.3)
| |
7.8 (6.0 to 9.9)
| |
|
N3
|
375 (0.9)
|
276
|
63.8 (58.7 to 68.5)
| |
6.2 (4.0 to 8.9)
| |
|
Stage
| | | |
<0.001
| |
< 0.001
|
|
I/II
|
37363 (93.3)
|
5889
|
4.8 (4.6 to 5.0)
| |
7.4 (7.1 to 7.7)
| |
|
III
|
2680 (6.7)
|
1327
|
37.8 (36.0–39.7)
| |
6.5 (5.7–7.5)
| |
-
Abbreviation: NOS malignant melanoma, not otherwise specified
